# US 2026/0092066 A1 · Novel synthetic options towards the manufacture of (6r,10s)-10-{4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6h)-pyrimidinyl}- 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6h)-one

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0092066 A1
- Document ID: US20260092066A1
- Status: Published application
- Kind: A1
- Application number: 19/242,506
- Filed: 2025-06-18
- Published: 2026-04-02
- Earliest claimed: 2019-04-11
- Assignees: Bristol-Myers Squibb Company; Janssen Pharmaceutica NV
- Applicants: Bristol-Myers Squibb Company; Janssen Pharmaceutica NV
- Inventors: Nicolas CUNIERE; Yu FAN; Sergei KOLOTUCHIN; Subha MUKHERJEE; Eric M. SIMMONS; Amarjit SINGH; Carolyn S. WEI; Yi XIAO; Changxia YUAN; Bin ZHENG; Simon Albert WAGSCHAL; Diego Fernando Domenico BROGGINI; Duy Chi Trung CAO; Kostiantyn CHERNICHENKO; Sebastien Francois Emmanuel LEMAIRE; Cyril Ben HAIM
- Web page: https://patentgrep.com/patent/US20260092066A1

## CPC

- C07D 471/18: Bridged systems
- C07D 213/61: Halogen atoms or nitro radicals
- C07D 401/04: directly linked by a ring-member-to-ring-member bond
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Highly efficient methods are provided for preparing key intermediates in the synthesis of Compound (I), which are broadly applicable and can provide selected components having a variety of substituents groups.

## Claims

### Claim at position 1

-12. (canceled)

### Claim 13

A process of making Compound 21:
comprising the steps of
a) reacting Compound 15
with (CH3O)2CH(CH2)2Br to yield Compound 16
b) converting Compound 16 to Compound 17 in the presence of an acid
c) reacting Compound 17 with a triphenyl phosphonium ylide or a phosphonate derivative in the presence of a suitable solvent to yield Compound 18
wherein R3′ is C1-6 alkyl;
d) reacting Compound 18 with a trimethyl orthoformate in the presence of an acid to yield Compound 19
e) converting Compound 19 to Compound 20
f) hydrogenating Compound 20 in the presence of a ruthenium catalyst to yield Compound 21

### Claim 14 (depends on 13)

The process of claim 13 in Step b), wherein the acid is TFA.

### Claim 15 (depends on 13)

The process of claim 13 in Step d), wherein the acid is selected from hydrochloric acid, sulfuric acid, methane sulfonic acid, and p-toluene sulfonic acid.

### Claim 16 (depends on 13)

The process of claim 13 in Step f), wherein the ruthenium catalyst is selected from dichloro[(R)-(+)-2,2′,6,6′-tetramethoxy-4,4′-bis(diphenylphosphino)-3,3′-bipyridine][(1R,2R)-(+)-1,2-diphenylethylenediamine]ruthenium(II), dichloro[(R)-(+)-2,2′-bis(diphenylphosphino)-1,1′-binaphthyl][(1R,2R—)-(+)-1,2-diphenylethylenediamine]ruthenium(II), dichloro[(S)-(−)-2,2′-bis(diphenylphosphino)-1,1′-binaphthyl]ruthenium(II), and diacetato[(R)-(+)-2,2′-bis(diphenylphosphino)-1,1′-binaphthyl]ruthenium(II).

### Claim 17

A process for the preparation of a compound of Formula (III):
wherein
R1 is methyl;
R2 is methyl;
R4 is NO2 and
R5 is CHF2;
comprising the steps of
1) reacting Compound 28
wherein X is selected from F, Cl, Br, and I,
with (triisopropylsilyl)acetylene to yield Compound 29
2) converting Compound 29 to Compound 30
3) subsequently reacting Compound 30 with bis(cyclopentadienyl) zirconium dichloride to yield Compound 31
4) subsequently reacting Compound 31 with(S)-(−)-3-methoxy-2-methyl-3-oxopropylzinc bromide to yield Compound 32
5) subsequently reacting Compound 32 in the presence of a metal catalyst with Compound 8
to yield Compound 33

### Claim 18

(canceled)

### Claim 19

A compound of Formula (II):
or a salt thereof, wherein
is an optional bond;
R1 is C1-6 alkyl;
R2 is C1-3 alkyl;
R3 is selected from OH, OC1-4 alkyl,
wherein
R6 is selected from C1-3 alkyl, phenyl, and benzyl;
R7 is selected from H and phenyl;
R8 is selected from C1-3 alkyl, phenyl, and benzyl; and
X is selected from F, Cl, Br and I.

### Claim 20 (depends on 19)

The compound or salt thereof of claim 19, wherein R1 is Me.

### Claim 21 (depends on 19)

The compound or salt thereof of claim 19, wherein R2 is Me.

### Claim 22 (depends on 19)

The compound or salt thereof of claim 19, having the structure of Compound 21:
or a salt thereof.

### Claim 23

A compound of Formula (III):
wherein
R1 is C1-6 alkyl;
R2 is C1-3 alkyl;
R4 is selected from NO2, N═O, NHOH, and NH2; and
R5 is selected from CHF2, CD3, and CH3.

### Claim 24 (depends on 23)

The compound of claim 23, wherein
R1 is methyl;
R2 is methyl;
R4 is selected from NO2 and NH2; and
R5 is CHF2.

### Claim 25 (depends on 23)

The compound of claim 23, having the structure of Compound 9a or Compound 10a:

### Claim 26

A compound of Formula (IV):
wherein
R1 is C1-6 alkyl;
R2 is C1-3 alkyl; and
R5 is selected from CHF2, CD3, and CH3.

### Claim 27 (depends on 26)

The compound of claim 26, wherein
R1 is methyl;
R2 is methyl; and
R5 is CHF2.

### Claim 28

A compound of Formula (V):
wherein
R2 is C1-3 alkyl; and
R5 is selected from CHF2, CD3, and CH3.

### Claim 29 (depends on 28)

The compound of claim 28, wherein R2 is methyl; and R5 is CHF2.

### Claim 30 (depends on 28)

The compound of claim 28, having the structure of Compound 12:

### Claim 31

A compound of Formula (VI):
or a salt thereof, wherein
R2 is C1-3 alkyl;
R3 is selected from OH, OC1-4 alkyl,
wherein
R6 is selected from C1-3 alkyl, phenyl, and benzyl;
R7 is selected from H and phenyl;
R8 is selected from C1-3 alkyl, phenyl, and benzyl; and
X is selected from F, Cl, Br and I.

### Claim 32 (depends on 31)

The compound or salt thereof of claim 31, wherein
R2 is C1-3 alkyl;
R3 is selected from OH, OC1-4 alkyl,
and
X is selected from F, Cl, Br and I.

### Claim 33 (depends on 31)

The compound or salt thereof of claim 31, having the structure of Compound 34:
